BBLGW BONE BIOLOGICS CORP C/WTS (TO P
$4.54▲ +0.00%
Unknown
Other
Volume 238
Avg Volume (10D) 540
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
3.50 - 35.95
% vs 50 MA
-51.53%
% vs 200 MA
-73.64%
RSI-14
26.6
MACD Histogram
-0.0800
Beta (1Y vs SPY)
-1.60
Free Cash Flow
-$518,440
Gross Rev
$0
Gross Profit
$0
EBITDA
-$807,998
COGS
–
Operating Exp
$808,106
Operating Income
-$808,106
EBIT
-$808,106
Pretax Income
-$773,702
Net Income
-$773,702
Price & Volume History
Loading chart…
Recent News
Bone Biologics Expands Trial Sites
GlobeNewswire · Sep 8, 2026 12:30 PM
Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 3, 2026 12:30 PM
Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months as NB1 Study Advances
InvestorsHub · Aug 12, 2026 2:15 PM
Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1
GlobeNewswire · Aug 12, 2026 12:00 PM
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
GlobeNewswire · Jul 23, 2026 12:00 PM
Bone Biologics Prices Up to $9 Million Private Placement of Stock, Warrants
MT Newswires · Jul 8, 2026 10:01 AM
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire · Jul 8, 2026 12:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See BBLGW's money flow as a full page
Social Sentiment
No Reddit posts found for BBLGW.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.